(Q47910909)

6 February 2018

title

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. (English)

1 reference

6 February 2018

1 reference

6

1 reference

6 February 2018

Augustus John Rush

1

object named as

Rush AJ

2 references

ORCID Public Data File 2021

6 February 2018

Jacques Montplaisir

10

object named as

Montplaisir J

1 reference

6 February 2018

author name string

Armitage R

2

1 reference

6 February 2018

Gillin JC

3

1 reference

6 February 2018

Yonkers KA

4

1 reference

6 February 2018

Winokur A

5

1 reference

6 February 2018

Vogel GW

7

1 reference

6 February 2018

Kaplita SB

8

1 reference

6 February 2018

Fleming JB

9

1 reference

6 February 2018

Erman MK

11

1 reference

6 February 2018

Albala BJ

12

1 reference

6 February 2018

McQuade RD

13

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

published in

Biological Psychiatry

1 reference

6 February 2018

volume

44

1 reference

6 February 2018

page(s)

3-14

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

The effects of nefazodone on sleep architecture in depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Fluoxetine and Oculomotor Activity during Sleep in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

A Multicenter, Double-Blind Comparison of the Effects of Nefazodone and Fluoxetine on Sleep Architecture and Quality of Sleep in Depressed Outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Fluoxetine-induced sleep disturbance in depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Effect of fluoxetine on sleep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

REM sleep enhancement by bupropion in depressed men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Nefazodone and imipramine in major depression: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

The inventory for depressive symptomatology (IDS): Preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Sleep patterns in depression and anxiety: theory and pharmacological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Nefazodone--a novel antidepressant--may increase REM sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Drug effects on REM sleep and on endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900092-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(98)00092-4

1 reference

6 February 2018

PubMed ID

9646878

1 reference

6 February 2018